Ads
related to: sanofi- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- News
Stay current on all things Vertex
and discover the latest news.
- Contact Us
Search results
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward
Reuters via Yahoo News· 1 hour agoFollowing the ruling, analysts at J.P. Morgan said the potential liability that GSK could face from...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 3 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 1 hour ago(Bloomberg) -- GSK Plc shares slumped in the wake of a court ruling that the UK drugmaker, alongside...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via AOL· 3 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 3 days agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Reuters via AOL· 2 days agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 7 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe US Food and Drug Administration (FDA) has accepted for priority review Sanofi's supplemental...
Sanofi’s Chronic Lung Disease Drug Gets EU Regulator Backing
Bloomberg· 3 days agoSanofi’s Dupixent is close to being approved in Europe for use in helping patients with a chronic...
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
Fortune via AOL· 5 days agoGood morning from Geneva. If generative AI is going to be more than hype and hallucinations, the...